|
[1]
|
Allan, M., Lièvre, M., Laurenson-Schafer, H., de Barros, S., Jinnai, Y., Andrews, S., et al. (2022) The World Health Organization COVID-19 Surveillance Database. International Journal for Equity in Health, 21, Article No. 167. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Carfì, A., Bernabei, R. and Landi, F. (2020) Persistent Symptoms in Patients after Acute Covid-19. JAMA, 324, 603-605. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Koc, H.C., Xiao, J., Liu, W., Li, Y. and Chen, G. (2022) Long COVID and Its Management. International Journal of Biological Sciences, 18, 4768-4780. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sanghvi, A.R. (2020) COVID‐19: An Overview for Dermatologists. International Journal of Dermatology, 59, 1437-1449. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gottlieb, M. and Long, B. (2020) Dermatologic Manifestations and Complications of Covid-19. The American Journal of Emergency Medicine, 38, 1715-1721. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Darabi, A., Dehghanfard, M., Jozan, S., Tahmasebi, R., Movahed, A., Zamani, M., et al. (2021) Investigating the Association between Allergic Diseases and COVID-19 in 400 Iranian Patients. Allergologia et Immunopathologia, 49, 9-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Bermingham, W.H., Ardern‐Jones, M.R., Huissoon, A.P. and Krishna, M.T. (2021) Forewarned Is Forearmed: Chronic Spontaneous Urticaria as a Potential Risk to Effective Sars‐COV‐2 Vaccine Uptake and Global Public Health. British Journal of Dermatology, 185, 838-839. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
曹瑜, 郑辉烈, 刘智涛, 等. 1990-2019年中国荨麻疹疾病负担现状及趋势[J]. 中国皮肤性病学杂志, 2022, 36(8): 905-910+19.
|
|
[9]
|
Akca, H.M. and Tuncer Kara, K. (2021) Evaluation of Urticaria Patients before and during the Period of the COVID‐19 Pandemic: A Retrospective Study. Dermatologic Therapy, 34, e14800. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Colmenero, I., Santonja, C., Alonso‐Riaño, M., Noguera‐Morel, L., Hernández‐Martín, A., Andina, D., et al. (2020) Sars‐Cov‐2 Endothelial Infection Causes COVID‐19 Chilblains: Histopathological, Immunohistochemical and Ultrastructural Study of Seven Paediatric Cases. British Journal of Dermatology, 183, 729-737. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Assil, S., Coléon, S., Dong, C., Décembre, E., Sherry, L., Allatif, O., et al. (2019) Plasmacytoid Dendritic Cells and Infected Cells Form an Interferogenic Synapse Required for Antiviral Responses. Cell Host & Microbe, 25, 730-745.e6. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cappel, M.A., Cappel, J.A. and Wetter, D.A. (2021) Pernio (Chilblains), Sars-Cov-2, and COVID Toes Unified through Cutaneous and Systemic Mechanisms. Mayo Clinic Proceedings, 96, 989-1005. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lim, K. and Staudt, L.M. (2013) Toll-Like Receptor Signaling. Cold Spring Harbor Perspectives in Biology, 5, a011247. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Barrat, F.J. and Su, L. (2019) A Pathogenic Role of Plasmacytoid Dendritic Cells in Autoimmunity and Chronic Viral Infection. Journal of Experimental Medicine, 216, 1974-1985. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Gallman, A.E. and Fassett, M.S. (2021) Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatologic Clinics, 39, 533-543. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zuo, Y., Estes, S.K., Ali, R.A., Gandhi, A.A., Yalavarthi, S., Shi, H., et al. (2020) Prothrombotic Autoantibodies in Serum from Patients Hospitalized with Covid-19. Science Translational Medicine, 12, Article No. 570. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Consiglio, C.R., Cotugno, N., Sardh, F., Pou, C., Amodio, D., Rodriguez, L., et al. (2020) The Immunology of Multisystem Inflammatory Syndrome in Children with Covid-19. Cell, 183, 968-981.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhang, T., Feng, H., Zou, X. and Peng, S. (2022) Integrated Bioinformatics to Identify Potential Key Biomarkers for Covid-19-Related Chronic Urticaria. Frontiers in Immunology, 13, Article ID: 1054445. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
李经纬. 中医大辞典[J]. 医学研究杂志, 1999, 33(6): 10-11.
|
|
[20]
|
余峥瑶, 马丽俐. 从“伏风引触”论治特应性皮炎[J]. 浙江中医杂志, 2024, 59(5): 377-380.
|
|
[21]
|
宋天平, 薛凯元, 袁锐, 等. 基于“伏邪化气”理论浅谈荨麻疹的病因病机及治疗[J]. 环球中医药, 2025(2): 80-83.
|
|
[22]
|
申荣旻, 张妍, 王济, 等. 王琦教授调体治疗过敏性疾病方法探微[J]. 北京中医药大学学报, 2016, 39(1): 73-76.
|
|
[23]
|
郑文科, 张俊华, 杨丰文, 等. 中医药防治新型冠状病毒肺炎各地诊疗方案综合分析[J]. 中医杂志, 2020, 61(4): 277-280.
|
|
[24]
|
叶放, 吴勉华, 程海波, 等. 国医大师周仲瑛教授《新型冠状病毒肺炎中医辨治方案》解读[J]. 南京中医药大学学报, 2020, 36(2): 141-144.
|
|
[25]
|
汪彬彬, 潘杰, 陈绍斌, 等. 78例新型冠状病毒肺炎患者舌象的初步研究[J]. 江苏中医药, 2020, 52(4): 84-86.
|
|
[26]
|
李静, 王伟, 高琴. 荨麻疹的中医药认识及论治方法进展[J]. 中医研究, 2023, 36(1): 87-92.
|
|
[27]
|
汪津禾, 任建勋, 李亚琴, 等. 从“皮肤间风”辨治慢性荨麻疹经验[J]. 北京中医药, 2024, 43(11): 1327-1330.
|
|
[28]
|
陈思珏, 曹炜, 肖显俊, 等. 新冠疫情流行期间COVID-19感染与诱发皮肤病的关联[J]. 中华医院感染学杂志, 2024, 34(11): 1720-1724.
|
|
[29]
|
杨世英, 张光霁. 从风邪论治过敏性疾病[J]. 山东中医杂志, 2010, 29(1): 8-9.
|
|
[30]
|
薛枫, 吕晓东. 玉屏风散合麻黄附子细辛汤治疗过敏性鼻炎的研究进展[J]. 中国实用医药, 2022, 17(21): 184-187.
|
|
[31]
|
肖经苪, 陈伟炳, 闫小兵, 等. 玉屏风散重用黄芪方治疗慢性荨麻疹及其对患者免疫功能的临床研究[J]. 中医临床研究, 2020, 12(25): 82-84.
|
|
[32]
|
阎博华, 唐健元, 丁红, 等. 中医药促进新型冠状病毒肺炎恢复期康复临床研究方案[J]. 成都中医药大学学报, 2020, 43(1): 1-6.
|
|
[33]
|
郝峰, 魏爽, 胡晓阳, 等. 李冀运用玉屏风散加减验案三则[J]. 辽宁中医杂志, 2019, 46(10): 2189-2191.
|